AVIR
Price
$2.87
Change
+$0.02 (+0.70%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
245.46M
13 days until earnings call
XOMA
Price
$24.06
Change
+$0.72 (+3.08%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
276.71M
19 days until earnings call
Ad is loading...

AVIR vs XOMA

Header iconAVIR vs XOMA Comparison
Open Charts AVIR vs XOMABanner chart's image
Atea Pharmaceuticals
Price$2.87
Change+$0.02 (+0.70%)
Volume$7.77K
Capitalization245.46M
XOMA Royalty
Price$24.06
Change+$0.72 (+3.08%)
Volume$207
Capitalization276.71M
AVIR vs XOMA Comparison Chart
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVIR vs. XOMA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a Hold and XOMA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (AVIR: $2.84 vs. XOMA: $23.34)
Brand notoriety: AVIR and XOMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 127% vs. XOMA: 68%
Market capitalization -- AVIR: $245.46M vs. XOMA: $276.71M
AVIR [@Biotechnology] is valued at $245.46M. XOMA’s [@Biotechnology] market capitalization is $276.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileXOMA’s FA Score has 1 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • XOMA’s FA Score: 1 green, 4 red.
According to our system of comparison, XOMA is a better buy in the long-term than AVIR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 5 TA indicator(s) are bullish while XOMA’s TA Score has 4 bullish TA indicator(s).

  • AVIR’s TA Score: 5 bullish, 5 bearish.
  • XOMA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AVIR is a better buy in the short-term than XOMA.

Price Growth

AVIR (@Biotechnology) experienced а -5.27% price change this week, while XOMA (@Biotechnology) price change was +13.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

AVIR is expected to report earnings on Aug 06, 2025.

XOMA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XOMA($277M) has a higher market cap than AVIR($245M). XOMA YTD gains are higher at: -11.187 vs. AVIR (-15.164). XOMA has higher annual earnings (EBITDA): -18.71M vs. AVIR (-192.53M). AVIR has more cash in the bank: 455M vs. XOMA (143M). AVIR has less debt than XOMA: AVIR (1.64M) vs XOMA (119M). XOMA has higher revenues than AVIR: XOMA (9.71M) vs AVIR (0).
AVIRXOMAAVIR / XOMA
Capitalization245M277M88%
EBITDA-192.53M-18.71M1,029%
Gain YTD-15.164-11.187136%
P/E RatioN/AN/A-
Revenue09.71M-
Total Cash455M143M318%
Total Debt1.64M119M1%
FUNDAMENTALS RATINGS
AVIR vs XOMA: Fundamental Ratings
AVIR
XOMA
OUTLOOK RATING
1..100
5423
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
1
Undervalued
PROFIT vs RISK RATING
1..100
9781
SMR RATING
1..100
9194
PRICE GROWTH RATING
1..100
7656
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XOMA's Valuation (1) in the Biotechnology industry is somewhat better than the same rating for AVIR (46). This means that XOMA’s stock grew somewhat faster than AVIR’s over the last 12 months.

XOMA's Profit vs Risk Rating (81) in the Biotechnology industry is in the same range as AVIR (97). This means that XOMA’s stock grew similarly to AVIR’s over the last 12 months.

AVIR's SMR Rating (91) in the Biotechnology industry is in the same range as XOMA (94). This means that AVIR’s stock grew similarly to XOMA’s over the last 12 months.

XOMA's Price Growth Rating (56) in the Biotechnology industry is in the same range as AVIR (76). This means that XOMA’s stock grew similarly to AVIR’s over the last 12 months.

AVIR's P/E Growth Rating (95) in the Biotechnology industry is in the same range as XOMA (100). This means that AVIR’s stock grew similarly to XOMA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVIRXOMA
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 17 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PQNCX16.14N/A
N/A
Virtus NFJ Mid-Cap Value C
FAAIX26.30N/A
N/A
Fidelity Advisor Asset Manager 70% I
NSFLX11.68N/A
N/A
Natixis Target Retirement 2055 N
VFMFX37.66N/A
N/A
Vanguard US Multifactor Admiral™
RYHOX62.77N/A
N/A
Rydex NASDAQ-100® H

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with IMNM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-0.98%
IMNM - AVIR
47%
Loosely correlated
+3.54%
HEPA - AVIR
47%
Loosely correlated
+0.68%
AXON - AVIR
46%
Loosely correlated
+3.82%
FHTX - AVIR
46%
Loosely correlated
+10.38%
KALV - AVIR
43%
Loosely correlated
+1.22%
More